Back
Philip Morris International, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Buy
58
PM
Philip Morris International, Inc.
Last Price:
$158.49
Seasonality Move:
2.61%
Sell
39
NKTR
Nektar Therapeutics
Last Price:
$53.91
Seasonality Move:
11.58%
Buy
58
Philip Morris International, Inc. (PM)
is a Buy
Is Philip Morris International, Inc. a Buy, Sell or Hold?
-
The current Philip Morris International, Inc. [PM] share price is $153.65. The Score for PM is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
PM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PM Stock Price Chart
What is Philip Morris International, Inc.'s stock price today?
-
The Philip Morris International, Inc. share price today is $153.65The current trend is relatively stagnant and PM is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $54.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
PM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.98 | Sell |
| Relative Strength Index (14 RSI): | 51.78 | Buy |
| Chaikin Money Flow: | 5589499 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (150.71 - 156.55) | Buy |
| Bollinger Bands (100): | (152.42 - 166) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | 141668 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.71 - 61.07) | Sell |
| Bollinger Bands (100): | (32.74 - 62.56) | Buy |
PM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 150.14 | Buy |
| 20-day SMA: | 153.24 | Buy |
| 50-day SMA: | 153.56 | Buy |
| 200-day SMA: | 163.94 | Sell |
| 8-day EMA: | 151.44 | Buy |
| 20-day EMA: | 152.36 | Buy |
| 50-day EMA: | 154.69 | Sell |
| 200-day EMA: | 156.08 | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.42 | Sell |
| 20-day SMA: | 58.12 | Sell |
| 50-day SMA: | 58.41 | Sell |
| 200-day SMA: | 30.65 | Buy |
| 8-day EMA: | 56.16 | Sell |
| 20-day EMA: | 57.43 | Sell |
| 50-day EMA: | 55.78 | Sell |
| 200-day EMA: | 37.86 | Buy |
Philip Morris International, Inc. Earnings Growth & PM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $0.79 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Philip Morris International, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||